Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promotor-methylated malignant astrocytoma.

Wick A,, Kessler T, Platten M, Meisner C, Bamberg M, Herrlinger U, Felsberg J, Weyerbrock A, Papsdorf K, Steinbach JP, Sabel M, Vesper J, Debus J, Meixensberger J, Ketter R, Hertler C, Mayer-Steinacker R, Weisang S, Bölting H, Reuss D, Reifenberger G, Sahm F, von Deimling A, Wick W; NOA-08 Study Group of the Neurooncology Working Group (NOA) of the German Cancer Society

Neuro Oncol. 2020;22: 1162 – 1172